Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran;Infection par le virus de l'hépatite c chez des patients polytransfusés et le personnel d'unités d'hémodialysedans le centre de la république islamique d'Iran

Eastern Mediterranean Health Journal

Volumn 18, Issue 3, 2012, Pages 227-235

  Samimi Rad, K ^a   Hosseini, M ^a   Mobeini, G ^a   Asgari, F ^a   Alavian, S M ^b   Tahaei, M E ^a   Salari, M H ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING DISORDER; BLOOD DONOR; BLOOD TRANSFUSION; DONOR SELECTION; GENOTYPE; HAEMODIALYSIS UNIT PERSONNEL; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; RISK FACTOR; THALASSEMIA;

EID: 84859141956     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2012.18.3.227     Document Type: Article

References (34)

1. Amir-Mohtashami Z, Jaafari Shakib A, Toorchi-roodsari H. Seroprevalence of hepatitis C and risk factors in hemodialysis patients in Guilan province, Iran Payesh, 2003, 4:291-295 [in Farsi].
2. Alavian SM et al. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology, 2003, 8:256-260.
3. Samimi-Rad K et al. Virus infection and hcv genotypes of hemodialysis patients. Iranian Journal of Public Health, 2008, 37:146-152.
4. Taziki O, Espahbodi F. Prevalence of hepatitis C virus infection in hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation, 2008, 19:475-478.
5. Assarehzadegan MA et al. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, Southwest Iran. Saudi Journal of Kidney Diseases and Transplantation, 2009, 20:681-684.
6. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia, 2007, 13:156-163.
7. Hariri MM et al. Prevalence of hepatitis B, C and HIV markers in thalassemic and hemophilic patients in Isfahan, 2004. Blood. The Scientific Journal of Iranian Blood Transfusion Organization Research Center, 2006, 2:201-204 [in Farsi].
8. Torabi SE et al. Prevalence of hepatitis B, C and HIV in hemophiliac patients of East Azarbaijan in 2004. Blood. The Scientific Journal of Iranian Blood Transfusion Organization Research Center, 2006, 2(Suppl. 7):291-299 [in Farsi].
9. Sharifi-Mood B et al. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Medical Journal, 2007, 28:1516-1519.
10. Abolghasemi H et al. Thalassemia in Iran: epidemiology, prevention, and management. Journal of Pediatric Hematology/ Oncology, 2007, 29:233-238.
11. Mirmomen S et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Archives of Iranian Medicine, 2006, 9:319-323.
12. Alavian SM et al. The efficacy of blood donor screening in reducing the incidence of hepatitis C virus infection among thalassemic patients in Iran. Transfusion Today, 2002, 53:3-4.
13. Stuyver L et al. Second-generation line probe assay for hepatitis C virus genotyping. Journal of Clinical Microbiology, 1996, 34:2259-2266.
14. Mansour-Ghanaei F et al. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Medical Science Monitor, 2002, 8:CR797-CR800.
15. Ghosh K et al. Transfusion transmitted diseases in haemophilics from western India. Indian Journal of Medical Research, 2000, 112:61-64.
16. Nakata S et al. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. Journal of Gastroenterology and Hepatology, 1994, 9:416-419.
17. Al-Kubaisy WA, Al-Naib KT, Habib MA. Prevalence of HCV/ HIV co-infection among haemophilia patients in Baghdad. Eastern Mediterranean Health Journal, 2006, 12:264-269.
18. Maor Y et al. Hepatitis C at the Israeli national hemophilia center. Haemophilia, 2006, 12:68-74.
19. Rezvan H, et al. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfusion Medicine, 2007, 17: 425-433.
20. Al-Kubaisy WA, Al-Naib KT, Habib M. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia. Eastern Mediterranean Health Journal, 2006, 12:204-210.
21. Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multi-transfused patients. Journal of Tropical Pediatrics, 2001, 47:239-242.
22. Marwaha RK et al. Seroprevalence of hepatitis C and B virus in multiply transfused beta-thalassemics: results from a thalassemic day care unit in north India. Vox Sanguinis, 2003, 85:119-120.
23. Ramia S et al. Hepatitis-C-virus genotypes and hepatitis-Gvirus infection in Lebanese thalassaemics. Annals of Tropical Medicine and Parasitology, 2002, 96:197-202.
24. Jadoul M et al. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrology, Dialysis, Transplantation, 2004, 19:904-909.
25. Huraib S et al. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrology, Dialysis, Transplantation, 1995, 10:470-474.
26. Bdour S. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. Journal of Medical Microbiology, 2002, 51:700-704.
27. Fabrizi F et al. Kinetics of hepatitis C virus load during hemodialysis: novel perspectives. Journal of Nephrology, 2003, 16:467-475.
28. Oliveira Penido JM et al. Seroprevalencia del virus de la hepatitis C en pacientes en hemodialisis y en profesionales de la salud en el Estado de Minas Gerais, region Sudeste de Brasil. [The seroprevalence of HCV in patients submitted to hemodialysis and health professionals in the State of Minas Gerais, southwest of Brazil]. Nefrologia, 2008, 28:178-185.
29. Saxena AK, Panhotra BR. The vulnerability of middle-aged and elderly patients to hepatitis C virus infection in a highprevalence hospital-based hemodialysis setting. Journal of the American Geriatrics Society, 2004, 52:242-246.
30. Arenas Jimenez MD, Sanchez-Paya J. Standard precautions in haemodialysis--the gap between theory and practice. Nephrology, Dialysis, Transplantation, 1999, 14:823-825.
31. Santos MA, Souto FJ. Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study. BMC Public Health, 2007, 7:32.
32. Grethe S et al. Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis. Journal of Medical Virology, 2000, 60:152-158.
33. Petrosillo N et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. American Journal of Kidney Diseases, 2001, 37:1004-1010.
34. Pujol FH et al. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. Journal of Clinical Microbiology, 1996, 34:1633-1636.